Ticker

No recent analyst price targets found for MYCOF.

Latest News for MYCOF

Noveris Health Sciences Provides Corporate Update, and Announces Agreement for Acquisition of Stem Cell Distribution Business

Vancouver, British Columbia – TheNewswire - April 29, 2026 – Noveris Health Sciences Inc. (the “ Company ”, or “ Noveris ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) wishes to provide a corporate update. Noveris is a biotech and life sciences company dedicated to developing and commercializing innovative solutions for treating mental health problems and enhancing vitality.  Following completion of the Company's debt…

TheNewswire • Apr 29, 2026
Noveris Health Sciences Inc. Announces Signing Of Market Making Advisory Agreement With DS Market Solutions Inc.

Vancouver, British Columbia, April 22, 2026 - TheNewswire – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce that it has entered into an advisory agreement (the “ Agreement ”) with DS Market Solutions Inc. (“ DSMS ”), pursuant to which DSMS will provide liquidity and stability services to the Company in accordance with the policies of the Canadian Securities…

TheNewswire • Apr 22, 2026
Noveris Health Sciences Inc. Provides Clarifying News Release Regarding Life Offering And Other Disclosure

Vancouver, British Columbia, April 20, 2026 – TheNewswire – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces that, as a result of a review by the British Columbia Securities Commission (the “ BCSC ”), the Company is issuing the following press release to clarify recent disclosure included in the Company's LIFE offering document dated March 11, 2026 (the “ LIFE Offering…

TheNewswire • Apr 20, 2026
Noveris Provides Announces Trading Halt Order, And Clarification As To Article

Vancouver, British Columbia, March 26, 2026 – TheNewswire – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) announces that the British Columbia Securities Commission (“ BCSC ”) issued an order dated March 25, 2026 under section 89(1) of the Securities Act (British Columbia) halting all trading in the Company's securities until April 16, 2026 (the “ Order ”) due to, among other…

TheNewswire • Mar 26, 2026
Noveris Announces Closing of Life Offering

Vancouver, British Columbia – TheNewswire - March 18, 2026 – Noveris Health Sciences Inc. (the “ Company ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce that it has completed its previously announced non-brokered private placement and issued  9,625,049 units (each, a “ Unit ”) at a price of $0.24 per Unit for gross proceeds of $2,310,011.76 (the “ Offering ”). Each Unit consists of: (i) one common…

TheNewswire • Mar 18, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for MYCOF.

No Senate trades found for MYCOF.

No House trades found for MYCOF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top